InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.00
(
0.00%
)
Bitcoin
59,220.52
(
0.19%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

suppress

Send PM Follow Ignore
Followers 60
Posts 2017
Boards Moderated 0
Alias Born 02/21/2013

suppress

Re: None

Wednesday, 05/08/2013 1:31:58 AM

Wednesday, May 08, 2013 1:31:58 AM

Post# of 158400
"The stellar academic record of Dr. Min and his continual involvement should not only help accelerate our therapeutics development process, but should also position us for numerous grant and philanthropic funding to support the ongoing translational development."

I just noticed this on their LOI PR for RNA gene silencing to treat cancer. It looks like they bought the patent to target grant funding. This could be good for BMSN if they can find grant funding to help them through clinical trials.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up